These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27981818)

  • 1. [Not Available].
    Fassio A; Idolazzi L; Rossini M; Viapiana O; Gatti D
    Reumatismo; 2016 Dec; 68(3):154-158. PubMed ID: 27981818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
    Gennari L; Merlotti D; Mossetti G; Rendina D; De Paola V; Martini G; Nuti R
    Mini Rev Med Chem; 2009 Aug; 9(9):1052-63. PubMed ID: 19689402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic acid for Paget's disease of bone.
    Maricic M
    Drugs Today (Barc); 2007 Dec; 43(12):879-85. PubMed ID: 18174973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effects of risedronate on Paget's disease of bone].
    Takata S
    Clin Calcium; 2006 Sep; 16(9):1508-12. PubMed ID: 16951476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of a single dose of zoledronic acid in a case of Paget bone disease].
    Saban M; Fidalgo S; Díaz CA; Lutfi RJ
    Medicina (B Aires); 2010; 70(5):445-8. PubMed ID: 20920964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of Paget's disease].
    Kurth AA
    Orthopade; 2007 Feb; 36(2):118, 120-3. PubMed ID: 17252256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paget's disease: case report].
    Wegierska M; Ignaczak P; Zalewska J; Jeka S
    Ann Acad Med Stetin; 2011; 57(3):64-9; discussion 69. PubMed ID: 23383549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone.
    Merlotti D; Gennari L; Martini G; Valleggi F; De Paola V; Avanzati A; Nuti R
    J Bone Miner Res; 2007 Oct; 22(10):1510-7. PubMed ID: 17605632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
    Martini G; Gennari L; Merlotti D; Salvadori S; Franci MB; Campagna S; Avanzati A; De Paola V; Valleggi F; Nuti R
    Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone.
    Merlotti D; Rendina D; Gennari L; Mossetti G; Gianfrancesco F; Martini G; De Filippo G; Avanzati A; Franci B; Campagna MS; Strazzullo P; Nuti R
    J Bone Miner Res; 2011 Mar; 26(3):512-8. PubMed ID: 20814970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission over 3 years in patients with Paget disease of bone treated with a single intravenous infusion of 5 mg zoledronic acid.
    Devogelaer JP; Geusens P; Daci E; Gielen E; Denhaerynck K; Macdonald K; Hermans C; Vancayzeele S; Abraham I; Boonen S
    Calcif Tissue Int; 2014 Mar; 94(3):311-8. PubMed ID: 24271562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease.
    Merlotti D; Rendina D; Muscariello R; Picchioni T; Alessandri M; De Filippo G; Materozzi M; Bianciardi S; Franci MB; Lucani B; Cenci S; Strazzullo P; Nuti R; Gennari L
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31634910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of Paget's disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS).
    Rendina D; Falchetti A; Diacinti D; Bertoldo F; Merlotti D; Giannini S; Cianferotti L; Girasole G; Di Monaco M; Gonnelli S; Malavolta N; Minisola S; Vescini F; Rossini M; Frediani B; Chiodini I; Asciutti F; Gennari L
    J Endocrinol Invest; 2024 Jun; 47(6):1335-1360. PubMed ID: 38488978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
    Polyzos SA; Anastasilakis AD; Makras P; Terpos E
    Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paget's Disease of Bone: Diagnosis and Treatment.
    Kravets I
    Am J Med; 2018 Nov; 131(11):1298-1303. PubMed ID: 29752905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent effect of zoledronic acid in Paget's disease.
    Tziomalos K; Florentin M; Krikis N; Perifanis V; Karagiannis A; Harsoulis F
    Clin Exp Rheumatol; 2007; 25(3):464-6. PubMed ID: 17631747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy.
    Pirih FQ; Zablotsky M; Cordell K; McCauley LK
    J Mich Dent Assoc; 2009 May; 91(5):38-43. PubMed ID: 19537656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current treatment approaches for Paget's Disease of Bone.
    Brandi ML
    Discov Med; 2010 Sep; 10(52):209-12. PubMed ID: 20875342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.
    Schweitzer DH; Zwinderman AH; Vermeij P; Bijvoet OL; Papapoulos SE
    J Bone Miner Res; 1993 Feb; 8(2):175-82. PubMed ID: 8442435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.